Bliss GVS Pharm has informed that the ESOP Allotment Committee of the Company, at its meeting held today, July 28, 2025, has approved the allotment of 74,000 equity shares of the face value of Re. 1/- each to the eligible employee who has exercised their stock options under Bliss GVS Pharma–Employee Stock Option Plan 2019 (‘Bliss GVS ESOP-2019’). Consequent to the aforesaid allotment, issued, subscribed & paid-up share capital of the Company has increased from ‘10,54,97,523 equity shares of Re. 1/- each aggregating Rs. 10,54,97,523 /-‘ to ‘10,55,71,522 equity shares of Re. 1/- each aggregating Rs. 10,55,71,522/-‘. In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 the details of shares allotted as above are given in ‘Annexure-I’ to this intimation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: